CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Delayed Terminal Ileal Perforation in a Relapsed/Refractory B-Cell Lymphoma Patient with Rapid Remission Following Chimeric Antigen Receptor T-Cell Therapy
Yongxian Hu, Jiasheng Wang, Chengfei Pu, Kui Zhao, Qu Cui, Guoqing Wei, Wenjun Wu, Lei Xiao, Yang Xiao, Jinping Wang, Zhao Wu, He Huang
Cancer Research and Treatment. 2018;50(4):1462-1466.   Published online 2018 February 5    DOI: https://doi.org/10.4143/crt.2017.473

Excel Download

Delayed Terminal Ileal Perforation in a Relapsed/Refractory B-Cell Lymphoma Patient with Rapid Remission Following Chimeric Antigen Receptor T-Cell Therapy
Cancer Research and Treatment. 2018;50(4):1462-1466   Crossref logo
Link1 Link2 Link3

653. Chimeric Antigen Receptor T-Cell Therapy for Companion Canines with Spontaneous B-Cell Non-Hodgkin Lymphoma
Molecular Therapy. 2013;21:S249   Crossref logo
Link1 Link2

14. Administration of GD2 Chimeric Antigen Receptor Modified, Tri-Virus Specific Cytotoxic T Lymphocytes after HLA Mismatched Allogeneic Stem Cell Transplantation for Relapsed, Refractory Neuroblastoma
Molecular Therapy. 2013;21:S5-S6   Crossref logo
Link1 Link2

768. Improved Chimeric Antigen Receptor-Engineered T Cells for the Treatment of Refractory and Relapsed Leukemia
Molecular Therapy. 2014;22:S296-S297   Crossref logo
Link1 Link2

765. Treatment of Chemotherapy-Refractory B-Cell Malignancies with Anti-CD19 Chimeric Antigen Receptor T Cells
Molecular Therapy. 2014;22:S295   Crossref logo
Link1 Link2

651. Tumor Targeting Using CD19-Specific CAR (Chimeric Antigen Receptor) for B-Cell Lymphoma
Molecular Therapy. 2013;21:S248-S249   Crossref logo
Link1 Link2

Temsirolimus in the treatment of relapsed or refractory mantle cell lymphoma
OncoTargets and Therapy. 2010;167   Crossref logo
Link1

CD19 Chimeric Antigen Receptor-Modified T Cell Immunotherapy in Ibrutinib-Refractory Chronic Lymphocytic Leukemia
Clinical Lymphoma Myeloma and Leukemia. 2017;17:S192-S193   Crossref logo
Link1 Link2

Tandem Induction Radiation and Chimeric Antigen Receptor T Cell Therapy in Patients with Relapsed or Refractory Non-Hodgkin Lymphoma
International Journal of Radiation Oncology*Biology*Physics. 2018;102(3):S122   Crossref logo
Link1 Link2

Remission of high-grade B-cell lymphoma in a pediatric patient following Helicobacter pylori eradication
Pediatrics International. 2011;53(1):105-107   Crossref logo
Link1

This metadata service is kindly provided by CrossRef from May 29, 2014. Cancer Res Treat has participated in CrossRef Text and Data Mining service since October 29, 2014.